Effect of sertraline on breathing in depressed patients without moderate-to-severe sleep-related breathing disorders

Sleep & Breathing = Schlaf & Atmung
Bin ZhangWuhan Liu

Abstract

Previous studies have reported that selective serotonin reuptake inhibitors (SSRIs) might improve sleep-related breathing disorders (SRBDs). However, the effects of SSRIs on breathing are not evaluated in subjects without moderate-to-severe SRBDs. Further, many symptoms of depression and SRBDs overlap, and so, it is interesting whether there are interactions between breathing and psychopathologic symptoms during SSRI treatment for depression. Data were taken from an open-label 8-week trial of sertraline in depressed patients with insomnia (n = 31). The depressed patients were administered 50 mg sertraline at 8 AM on the first day, and the dosage was subsequently titrated up to a maximum of 200 mg/day during the 8-week trial. All the patients were tested by repeated polysomnography (PSG) (baseline, 1st day, 14th day, 28th day, and 56th day). Sleep-disordered breathing events were categorized as apneas, hypopneas, and respiratory event-related arousals (RERAs). The clinical responses and PSG characteristics improved continuously during the 8-week trial. From the 14th day on, the RERA index during all-night and non-rapid eye movement (NREM) sleep became stable and significantly higher than baseline and the first day (RERA index 7....Continue Reading

References

Feb 1, 1992·The American Review of Respiratory Disease·R B BerryR W Light
Jun 20, 1989·European Journal of Pharmacology·A SchmidtJ Heym
May 23, 1983·Brain Research·M SallanonM Jouvet
Nov 1, 1996·Respiration Physiology·C R Richmonds, D W Hudgel
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Apr 19, 2000·JAMA : the Journal of the American Medical Association·F J NietoT G Pickering
Nov 14, 2001·Current Opinion in Pulmonary Medicine·R Zozula, R Rosen
May 10, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·B OndzeA Besset
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 6, 2003·Psychiatry Research·Rosalind CartwrightJulie Kabat
Dec 20, 2003·American Journal of Respiratory and Critical Care Medicine·Magdy Younes
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Sigrid C Veasey
Apr 24, 2007·Clinical Psychology Review·Stephanie L Burcusa, William G Iacono
Jul 15, 2009·Sleep Medicine Reviews·Melanie HarrisRonald R Grunstein
Nov 17, 2010·Nature Reviews. Cardiology·Malcolm Kohler, John R Stradling
Feb 9, 2011·Journal of Affective Disorders·Chiara BaglioniDieter Riemann
Dec 23, 2011·Journal of the American Geriatrics Society·Terri BlackwellUNKNOWN Osteoporotic Fractures in Men Study Group
Jan 11, 2012·Journal of Speech, Language, and Hearing Research : JSLHR·Mary BehanNadine P Connor
Aug 6, 2013·Lancet·Amy S JordanAtul Malhotra

❮ Previous
Next ❯

Citations

Apr 6, 2019·Sleep & Breathing = Schlaf & Atmung·Aysegul Altintop Geckil, Hilal Ermis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.